Uncategorized

Expanded facility integrates Syngoi Technologies’ enzymatic DNA platform into Artis’ North American operations, ensuring resilient,…

Bilbao, 14 de enero de 2026 — Columbus Venture Partners, gestora española de capital riesgo…